Eric J. Di Gravio
Papers
1
Total Citations
13
H-Index
1
About
Eric J. Di Gravio is a radiation oncologist whose research centers on optimizing treatment outcomes for head and neck cancers, particularly oropharyngeal malignancies. His major contributions lie in evaluating modern radiotherapy techniques, such as intensity-modulated radiation therapy (IMRT), and comparing their efficacy and toxicity profiles against emerging surgical approaches like transoral robotic surgery (TORS). In his most cited work, "Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution" (2020, 13 citations), Di Gravio provides critical evidence that primary radiotherapy remains a highly effective and well-tolerated option for early-stage disease, challenging assumptions that surgery inherently yields superior quality of life. This study has informed clinical decision-making by highlighting the nuanced trade-offs between treatment modalities. Di Gravio’s research is particularly impactful for students and clinicians navigating the evolving landscape of head and neck oncology, as it underscores the importance of personalized, evidence-based care. His work continues to shape discussions on de-escalation strategies and long-term survivorship, making him a valuable voice in the field.
Research Focus
Key Achievements
Top Papers
- 1